Bladder cancer claims are particularly strong in Zantac lawsuits due to the way NDMA forms and travels in the body. In the case of Zantac, the NDMA forms primarily after ingestion when the ranitidine molecule breaks down in the stomach and digestive system. This late formation allows more NDMA to reach the bladder, making bladder cancer a more likely outcome of Zantac use.